Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Drug Discovery Today
|
December 27, 2005
Predicting protein druggability
Philip J Hajduk, Jeffrey R Huth, Christin Tse
Cancer Research
|
January 26, 2002
Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line
Christin Tse, Ruinua H Xiang, Todd Bracht, et al.
Cancer Research
|
May 1, 2002
Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice
RuiHua Xiang, Albert R Davalos, Charles H Hensel, et al.
Molecular Cancer Therapeutics
|
February 25, 2010
Identification of expression signatures predictive of sensitivity to the Bcl-2 family member inhibitor ABT-263 in small cell lung carcinoma and leukemia/lymphoma cell lines
Stephen K Tahir, John Wass, Mary K Joseph, et al.
Cancer Chemotherapy and Pharmacology
|
January 26, 2010
The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
Scott Ackler, Michael J Mitten, Kelly Foster, et al.
Cancer Research
|
February 7, 2007
Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737
Stephen K Tahir, Xiufen Yang, Mark G Anderson, et al.
Molecular Cancer Therapeutics
|
October 15, 2008
ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo
Scott Ackler, Yu Xiao, Michael J Mitten, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2010
N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors
Milan Bruncko, Stephen K Tahir, Xiaohong Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models
Alex R Shoemaker, Michael J Mitten, Jessica Adickes, et al.
Cancer Research
|
May 3, 2008
ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse, Alexander R Shoemaker, Jessica Adickes, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Drug Discovery Today
|
December 27, 2005
Predicting protein druggability
Philip J Hajduk, Jeffrey R Huth, Christin Tse
Cancer Research
|
January 26, 2002
Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line
Christin Tse, Ruinua H Xiang, Todd Bracht, et al.
Cancer Research
|
May 1, 2002
Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice
RuiHua Xiang, Albert R Davalos, Charles H Hensel, et al.
Molecular Cancer Therapeutics
|
February 25, 2010
Identification of expression signatures predictive of sensitivity to the Bcl-2 family member inhibitor ABT-263 in small cell lung carcinoma and leukemia/lymphoma cell lines
Stephen K Tahir, John Wass, Mary K Joseph, et al.
Cancer Chemotherapy and Pharmacology
|
January 26, 2010
The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
Scott Ackler, Michael J Mitten, Kelly Foster, et al.
Cancer Research
|
February 7, 2007
Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737
Stephen K Tahir, Xiufen Yang, Mark G Anderson, et al.
Molecular Cancer Therapeutics
|
October 15, 2008
ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo
Scott Ackler, Yu Xiao, Michael J Mitten, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2010
N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors
Milan Bruncko, Stephen K Tahir, Xiaohong Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models
Alex R Shoemaker, Michael J Mitten, Jessica Adickes, et al.
Cancer Research
|
May 3, 2008
ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse, Alexander R Shoemaker, Jessica Adickes, et al.
Page
of 2